US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

8  9  10  11    13    15  16  17  
50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Anti-CD19 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Biotechnology Instrumentation (DNA Sequencing Systems, DNA Synthesizers, etc.)
7/1/2016 | published by: Global Industry Analysts
... Laboratory Automation, Liquid Chromatography Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are ...  |  read more...
USD 4,950
Anti-CD3 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Global Multi-Enzyme Detergent Market Research Report 2016
7/18/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Multi-Enzyme Detergent basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global Polyhydroxyalkanoates (PHA) Industry 2016 Market Research Report
7/28/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Polyhydroxyalkanoates (PHA) basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Anti-CD30 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Immunodiagnostics: Spot Fast-Growing Market Segments - Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
8/2/2016 | published by: VPGMarketResearch.com
... trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features ...  |  read more...
USD 24,500
Tumor Markers: Unlocking Mystery of the Genetic Basis of Cancer - Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
8/2/2016 | published by: VPGMarketResearch.com
... current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnosticsmarket during the next five years. Highlights - Business and technological trends in seven major markets: France, Germany, Italy, ...  |  read more...
USD 24,500
Animal Health: Accelerated Rate of Change and Regulatory Uncertainty Confronting the Industry - Performance, Capabilities, Goals and Strategies of Leading Animal Health Companies
8/2/2016 | published by: VPGMarketResearch.com
... and leading suppliers' strategies, marketing tactics, and technological know-how. The report presents a worldwide strategic overview of the animal health market, including: Five-year forecasts for: -Major market segments -Key geographic regions Assessment of major U.S. ...  |  read more...
USD 3,850
DNA Probes-Based Diagnostics (Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Others)
7/1/2016 | published by: Global Industry Analysts
... Predisposition, Identity/Forensics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a ...  |  read more...
USD 4,500
Protein Labeling Market Analysis By Product, (Enzymes, Reagents, Proteins, Monoclonal Antibodies, Probes/Tags), By Application (Immunological Techniques, Mass Spectroscopy, Protein Microarray, Cell Based Assay, Fluorescence Microscopy), By Labeling Techni
7/25/2016 | published by: Grand View Research
... 2024 Global protein labeling market is anticipated to reach USD 2,602.0 million by 2024, according to a new report by Grand View Research, Inc.Growing adoption of bioengineering technologies and rise in spending on R&D leading ...  |  read more...
USD 4,700
Global Virus Filtration Consumption Industry 2016 Market Research Report
8/1/2016 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure. The Virus Filtration market analysis is provided for the international market including development history, competitive landscape analysis, and major regions¡¯ development status. Secondly, development policies and plans are ...  |  read more...
USD 2,800
Anti-CD37 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review
7/5/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Biologics IP – A Strategic Review (TechVision)
8/10/2016 | published by: Frost & Sullivan
... companies were analyzed and segmented by biologics type (e.g., peptides, antibodies, vaccines etc.) and therapeutic area for competitive benchmarking. This study will help pharma-biotech companies understand the competitive landscape and the available white space from ...  |  read more...
USD 4,950
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities ...  |  read more...
USD 1,250
8  9  10  11    13    15  16  17